Luna Prieto Garcia
Doktorand vid Institutionen för farmaceutisk biovetenskap; Forskning; Translationell läkemedelsutveckling
- E-post:
- luna.prietogarcia@uu.se
- Besöksadress:
- BMC, Husargatan 3
75124 Uppsala - Postadress:
- Box 591
75124 Uppsala
Publikationer
Senaste publikationer
Ingår i AAPS Journal, 2025
- DOI för Integrated Physiologically-Based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 1: Model Development and Validation
- Ladda ner fulltext (pdf) av Integrated Physiologically-Based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 1: Model Development and Validation
Ingår i AAPS Journal, 2025
- DOI för Integrated Physiologically-based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 2: MIDD and MIPD Applications
- Ladda ner fulltext (pdf) av Integrated Physiologically-based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 2: MIDD and MIPD Applications
Ingår i CPT, s. 1029-1043, 2024
- DOI för Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins
- Ladda ner fulltext (pdf) av Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins
2023
Ingår i Clinical Pharmacology and Therapeutics, s. 825-835, 2023
- DOI för Understanding Statin-Roxadustat Drug–Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling
- Ladda ner fulltext (pdf) av Understanding Statin-Roxadustat Drug–Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling
Alla publikationer
Artiklar i tidskrift
Ingår i AAPS Journal, 2025
- DOI för Integrated Physiologically-Based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 1: Model Development and Validation
- Ladda ner fulltext (pdf) av Integrated Physiologically-Based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 1: Model Development and Validation
Ingår i AAPS Journal, 2025
- DOI för Integrated Physiologically-based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 2: MIDD and MIPD Applications
- Ladda ner fulltext (pdf) av Integrated Physiologically-based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 2: MIDD and MIPD Applications
Ingår i CPT, s. 1029-1043, 2024
- DOI för Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins
- Ladda ner fulltext (pdf) av Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins
Ingår i Clinical Pharmacology and Therapeutics, s. 825-835, 2023
- DOI för Understanding Statin-Roxadustat Drug–Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling
- Ladda ner fulltext (pdf) av Understanding Statin-Roxadustat Drug–Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling
Ingår i CPT, s. 1194-1209, 2022
- DOI för Does the choice of applied physiologically-based pharmacokinetics platform matter?: A case study on simvastatin disposition and drug-drug interaction
- Ladda ner fulltext (pdf) av Does the choice of applied physiologically-based pharmacokinetics platform matter?: A case study on simvastatin disposition and drug-drug interaction
Ingår i Drug Metabolism And Disposition, s. 1420-1433, 2018